MedPageToday - July 8, 2022
Eric Hollander, M.D., discusses results of a large, randomized clinical trial that found the drug balovaptan did not improve socialization and communication among those with pediatric autism spectrum disorder (ASD). Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore and Einstein.
Additional coverage includes Medscape
Dr. Hollander's ProfileMore coverage on Dr. Hollander
The City - July 5, 2022
Antoinette Danvers, M.D., explains the importance of abortion training and Montefiore and Einstein's efforts to offer it to medical residents in states where abortion is now illegal. Dr. Danvers is associate professor of obstetrics & gynecology and women's health at Einstein and director of the division of complex family planning at Montefiore.
Dr. Danvers' Profile
MedPageToday - July 1, 2022
In a MedPage Today commentary, Einstein medical students Sarah McNeilly and Vivian Kim call for national organizations overseeing medical education to implement a universal curricular standard for abortion education.
Academic Minute - June 22, 2022
Steven Walkley, D.V.M., Ph.D., describes "gene teams" at Einstein and Montefiore in which physicians and scientists provide clinical information and research updates to parents of children diagnosed with rare genetic diseases. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology.
Dr. Walkley's ProfileMore coverage on Dr. Walkley
MedPageToday - June 19, 2022
Liise-anne Pirofski, M.D., co-authored a commentary on the benefits of convalescent plasma for treating immunocompromised patients who have COVID-19. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
The Scientist - June 16, 2022
Meredith Hawkins, M.D., M.S., explains her study that describes a metabolically distinct type of diabetes characterized by low body weight and problems with insulin secretion—a crucial step toward developing effective treatments. Dr. Hawkins is the founding director of the Global Diabetes Institute, professor of medicine, and the Harold and Muriel Block Chair in Medicine at Einstein.
Additional coverage includes UPI and The Hindu
Dr. Hawkins' ProfileMore coverage on Dr. Hawkins
Medscape - June 1, 2022
Noa Schwartz, M.D., M.S., comments on the discovery of a rare mutation in a person with systemic lupus erythematosus and the possibility that it could lead to new treatments for a subset of patients with the disease. Dr. Schwartz is assistant professor of medicine at Einstein and director of the Montefiore-Einstein Institute for Lupus Care and Research.
Dr. Schwartz's Profile
CNN - May 31, 2022
Joe Verghese, M.B.B.S., M.S., comments on a study that found adults over age 65 had an increased risk of dementia if they had both a decrease in their walking speed and signs of cognitive function decline. Dr. Verghese is chief of the integrated divisions of cognitive and motor aging and of geriatrics at Einstein and Montefiore. He also is the Murray D. Gross Memorial Faculty Scholar in Gerontology, director of the Resnick Gerontology Center, and professor in the Saul R. Korey Department of Neurology and of medicine at Einstein.
Additional coverage includes MedPage Today, Medscape
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The New York Times - May 31, 2022
Simon Rego, Psy.D., says looking forward to things improves our mood and can make us less irritable. Dr. Rego is associate professor of psychiatry and behavioral sciences, chief of psychology, and director of psychology training at Einstein and Montefiore.
Dr. Rego's ProfileMore coverage on Dr. Rego
WNYC - May 26, 2022
Seth Congdon, M.D., describes the common and often debilitating symptoms of long COVID and stresses the importance of following up with physicians and specialists to address them. Dr. Congdon is assistant professor of medicine at Einstein and medical co-director of the COVID-19 Recovery (CORE) Clinic at Montefiore.
Dr. Congdon's Profile
New York Social Diary - May 25, 2022
The Women's Division of Albert Einstein College of Medicine recently held its 67th Spirit of Achievement Luncheon, an annual fundraiser to support biomedical research. The event has raised more than $100 million since its inception.
Additional coverage includes WWD, Park Magazine NY, and Silver Disobedience
Slate - May 25, 2022
Deepika Slawek, M.D., M.S., explains that a harm reduction approach to COVID-19 means using a range of mitigation measures—such as vaccines, boosters, frequent testing, medical-grade masks, and improved ventilation—to lower the risk of contracting the virus. Dr. Slawek is assistant professor of medicine at Einstein and an internist and infectious disease physician at Montefiore.
Dr. Slawek's ProfileMore coverage on Dr. Slawek
BronxNet - May 18, 2022
Jeannette Mahoney, Ph.D., discusses her new NIH grant to examine sensory systems in the brain and detect behavioral markers for Alzheimer's disease. Dr. Mahoney is assistant professor in the Saul R. Korey Department of Neurology at Einstein.
Dr. Mahoney's Profile
NPR - May 10, 2022
Priya Nori, M.D., says people who are diagnosed with COVID-19 benefit from taking the antiviral medication Paxlovid, even if they have been vaccinated or previously infected. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and medical director of the antimicrobial stewardship program at Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
The New York Times - May 10, 2022
Shelby Freedman Harris, Psy.D., says infants and preschoolers commonly move around during sleep and may end up in positions adults think are awkward, but are comfortable for children. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein. (subscription required)
Dr. Harris's ProfileMore coverage on Dr. Harris
Drug Discovery News - April 17, 2022
Nicholas Baker, Ph.D., discusses a study that discovered how epithelial cells interact with precancerous cells, recognizing them and removing them from the body. Dr. Baker is professor of genetics, of developmental and molecular biology, and of ophthalmology and visual sciences, and is the Harold and Muriel Block Chair in Genetics.
Dr. Baker's ProfileMore coverage on Dr. Baker
Healio - January 26, 2022
Tiffany Lu, M.D., M.S., describes her grant that will fund the expansion of addiction medicine and training programs for medical students and residents at Einstein and Montefiore. The curriculum will focus on the diagnosis and care for people with opioid use disorder, including guidance about medications for addiction treatment, particularly buprenorphine. Dr. Lu is assistant professor of medicine at Einstein and director of the Montefiore Buprenorphine Treatment Network.
Dr. Lu's Profile
Review of Ophthamology - October 10, 2021
Roy Chuck, M.D., Ph.D., describes the benefits of a new contact lens-like device, patented by Montefiore and Einstein, that is used in a treatment for keratoconus, an eye disease that affects the structure of the cornea. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
Dr. Ovryn's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile